Kimberly Desanctis
Family · Rumford, MENPI 1932614161
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Novo Nordisk at 27.0% of the total. Reporting peaked in 2022 at $530 and has fallen 77.9% since, to $117 in 2025. Among family clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$428
- GSK$369
- AbbVie$171
- Lilly USA, LLC$111
- Takeda Pharmaceuticals U.S.A., Inc.$95
- Boehringer Ingelheim$67
- plus $342 from 12 others
What the payments were for
- Food & beverage$1,583100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $428 |
| GSK | 19 | $369 |
| AbbVie | 10 | $171 |
| Lilly USA, LLC | 6 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| Boehringer Ingelheim | 3 | $67 |
| Merck | 3 | $60 |
| Pfizer | 2 | $38 |
| Bayer | 2 | $37 |
| Astellas Pharma US Inc | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Corcept Therapeutics | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Corium, LLC | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$125
How this compares
$1,583 in reported general payments places this provider in the 90th percentile of 545 family providers in Maine.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 31 | $37,035 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $20,202 |
| EliquisApixaban | 27 | $18,317 |
| JardianceEmpagliflozin | 26 | $15,439 |
| Repatha SyringeEvolocumab | 11 | $6,362 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $1,197 |
| Levothyroxine Sodium | 79 | $1,181 |
| Atorvastatin Calcium | 115 | $999 |
| Bupropion XlBupropion Hcl | 29 | $987 |
| Glipizide | 11 | $814 |
| Gabapentin | 19 | $455 |
| Losartan Potassium | 51 | $446 |
| Metoprolol Succinate | 33 | $442 |
| Perphenazine | 16 | $441 |
| Duloxetine Hcl | 19 | $351 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $428 | $37,03531 claims |
| GSKBreo Ellipta | $369 | $20,20220 claims |
| PfizerEliquis | $38 | $18,31727 claims |
| Boehringer IngelheimJardiance | $67 | $15,43926 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 545 family providers in Maine.
Other family in Rumford
- Mia RapollaFalmouth$193K
- Patti DupreyKennebunk$35K
- Amanda WilliamsPortland$8K
- Jamie PiacentiniScarborough$6K
- Rosemary PainePortland$6K
- Brea SwihartAugusta$5K
- Kristen Schroeder-CyrBrunswick$5K
- Liana KellyBrunswick$5K
- Natalie BubierLewiston$5K
- Holly JamesYork$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.